115 related articles for article (PubMed ID: 16760655)
1. CDK2 is required by MYC to induce apoptosis.
Deb-Basu D; Aleem E; Kaldis P; Felsher DW
Cell Cycle; 2006 Jun; 5(12):1342-7. PubMed ID: 16760655
[TBL] [Abstract][Full Text] [Related]
2. MYC can enforce cell cycle transit from G1 to S and G2 to S, but not mitotic cellular division, independent of p27-mediated inihibition of cyclin E/CDK2.
Deb-Basu D; Karlsson A; Li Q; Dang CV; Felsher DW
Cell Cycle; 2006 Jun; 5(12):1348-55. PubMed ID: 16760657
[TBL] [Abstract][Full Text] [Related]
3. Myc, Cdk2 and cellular senescence: Old players, new game.
Campaner S; Doni M; Verrecchia A; Fagà G; Bianchi L; Amati B
Cell Cycle; 2010 Sep; 9(18):3655-61. PubMed ID: 20818171
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation.
Hydbring P; Bahram F; Su Y; Tronnersjö S; Högstrand K; von der Lehr N; Sharifi HR; Lilischkis R; Hein N; Wu S; Vervoorts J; Henriksson M; Grandien A; Lüscher B; Larsson LG
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):58-63. PubMed ID: 19966300
[TBL] [Abstract][Full Text] [Related]
5. Cdk2 suppresses cellular senescence induced by the c-myc oncogene.
Campaner S; Doni M; Hydbring P; Verrecchia A; Bianchi L; Sardella D; Schleker T; Perna D; Tronnersjö S; Murga M; Fernandez-Capetillo O; Barbacid M; Larsson LG; Amati B
Nat Cell Biol; 2010 Jan; 12(1):54-9; sup pp 1-14. PubMed ID: 20010815
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inactivation of CDK2 inhibits MYC/BCL-XL-driven leukemia in vivo through induction of cellular senescence.
Bazzar W; Bocci M; Hejll E; Högqvist Tabor V; Hydbring P; Grandien A; Alzrigat M; Larsson LG
Cell Cycle; 2021 Jan; 20(1):23-38. PubMed ID: 33356836
[TBL] [Abstract][Full Text] [Related]
7. Cdk2 deficiency decreases ras/CDK4-dependent malignant progression, but not myc-induced tumorigenesis.
Macias E; Kim Y; Miliani de Marval PL; Klein-Szanto A; Rodriguez-Puebla ML
Cancer Res; 2007 Oct; 67(20):9713-20. PubMed ID: 17942901
[TBL] [Abstract][Full Text] [Related]
8. Cyclin A but not cyclin D1 is essential for c-myc-modulated cell-cycle progression.
Qi Y; Tu Y; Yang D; Chen Q; Xiao J; Chen Y; Fu J; Xiao X; Zhou Z
J Cell Physiol; 2007 Jan; 210(1):63-71. PubMed ID: 17013808
[TBL] [Abstract][Full Text] [Related]
9. Tipping the balance: Cdk2 enables Myc to suppress senescence.
Hydbring P; Larsson LG
Cancer Res; 2010 Sep; 70(17):6687-91. PubMed ID: 20713526
[TBL] [Abstract][Full Text] [Related]
10. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.
Vlach J; Hennecke S; Alevizopoulos K; Conti D; Amati B
EMBO J; 1996 Dec; 15(23):6595-604. PubMed ID: 8978686
[TBL] [Abstract][Full Text] [Related]
11. Constitutive CCND1/CDK2 activity substitutes for p53 loss, or MYC or oncogenic RAS expression in the transformation of human mammary epithelial cells.
Junk DJ; Cipriano R; Stampfer M; Jackson MW
PLoS One; 2013; 8(2):e53776. PubMed ID: 23390492
[TBL] [Abstract][Full Text] [Related]
12. Deregulated expression of CDK2- or CDK3-associated kinase activities enhances c-Myc-induced apoptosis.
Braun K; Hölzl G; Pusch O; Hengstschläger M
DNA Cell Biol; 1998 Sep; 17(9):789-98. PubMed ID: 9778038
[TBL] [Abstract][Full Text] [Related]
13. p27Kip1 mediates addiction of ovarian cancer cells to MYCC (c-MYC) and their dependence on MYC paralogs.
Prathapam T; Aleshin A; Guan Y; Gray JW; Martin GS
J Biol Chem; 2010 Oct; 285(42):32529-38. PubMed ID: 20647308
[TBL] [Abstract][Full Text] [Related]
14. AP4 is required for mitogen- and c-MYC-induced cell cycle progression.
Jackstadt R; Hermeking H
Oncotarget; 2014 Sep; 5(17):7316-27. PubMed ID: 25261373
[TBL] [Abstract][Full Text] [Related]
15. Deregulation of Cdk2 causes Bim-mediated apoptosis in p53-deficient tumors following actin damage.
Chae HD; Kim BM; Yun UJ; Shin DY
Oncogene; 2008 Jul; 27(29):4115-21. PubMed ID: 18345036
[TBL] [Abstract][Full Text] [Related]
16. The role of XPD in cell apoptosis and viability and its relationship with p53 and cdk2 in hepatoma cells.
Wang HY; Xiong GF; Zhang JX; Xu H; Guo WH; Xu JJ; Xiong XY
Med Oncol; 2012 Mar; 29(1):161-7. PubMed ID: 21264535
[TBL] [Abstract][Full Text] [Related]
17. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
Benaud CM; Dickson RB
Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
[TBL] [Abstract][Full Text] [Related]
18. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
Greider C; Chattopadhyay A; Parkhurst C; Yang E
Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
[TBL] [Abstract][Full Text] [Related]
19. Quiescence versus apoptosis: Myc abundance determines pathway of exit from the cell cycle.
Helbing CC; Wellington CL; Gogela-Spehar M; Cheng T; Pinchbeck GG; Johnston RN
Oncogene; 1998 Sep; 17(12):1491-501. PubMed ID: 9794226
[TBL] [Abstract][Full Text] [Related]
20. Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity.
Berns K; Hijmans EM; Bernards R
Oncogene; 1997 Sep; 15(11):1347-56. PubMed ID: 9315103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
